ClinicalTrials.Veeva

Menu

Examining Choice Architecture for Genetic Testing Decisions

Boston College logo

Boston College

Status

Completed

Conditions

Decision Making

Treatments

Behavioral: opt-in decision frame
Behavioral: choice decision frame
Behavioral: opt-out decision frame
Behavioral: enhanced choice (norms) decision frame
Behavioral: enhanced choice (affect) decision frame
Behavioral: enhanced choice (context) decision frame

Study type

Interventional

Funder types

Other

Identifiers

NCT04372888
20.205.01e

Details and patient eligibility

About

The goal of this application is to gain a deeper understanding of decision-making for genetic testing and identify effective choice-architecture-based strategies to improve decisions in genetic testing. The investigators hypothesize that choice architecture (i.e. framing) affects decision-making for hypothetical genetic testing scenarios.

Full description

After providing opt-in electronic consent, eligible consented participants will be randomized to one of two hypothetical genetic testing scenarios (rare, life-altering genetic condition or common, life-threatening genetic condition). The genetic testing scenarios include brief detailed information about genetic testing (i.e. how results may influence treatment decisions) as well as information about standard approaches to treatment. Subjects will be randomized to receive a framing conditions (e.g. choice, opt-in, opt-out, enhanced choice). Participants will select a preferred testing option to the hypothetical scenario and will complete several validated instruments.

Enrollment

1,012 patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult participants (18-64 yrs) residing in North America (who are members of the Amazon Mechanical Turk platform)

Exclusion criteria

  • age <18yrs or >65yrs or residing outside of North America

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,012 participants in 2 patient groups

rare genetic disease
Other group
Description:
Hypothetical scenario 1: rare, life-altering genetic condition (congenital hypogonadotropic hypogonadism)
Treatment:
Behavioral: enhanced choice (affect) decision frame
Behavioral: enhanced choice (context) decision frame
Behavioral: enhanced choice (norms) decision frame
Behavioral: opt-out decision frame
Behavioral: choice decision frame
Behavioral: opt-in decision frame
common genetic disease
Other group
Description:
Hypothetical scenario 2: common, life-threatening genetic condition (hereditary breast and ovarian cancer)
Treatment:
Behavioral: enhanced choice (affect) decision frame
Behavioral: enhanced choice (context) decision frame
Behavioral: enhanced choice (norms) decision frame
Behavioral: opt-out decision frame
Behavioral: choice decision frame
Behavioral: opt-in decision frame

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems